| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 09/26/2002 | WO2002074750A1 Metalloproteinase inhibitors |
| 09/26/2002 | WO2002074749A1 Metalloproteinase inhibitors |
| 09/26/2002 | WO2002074748A1 Metalloproteinase inhibitors |
| 09/26/2002 | WO2002074747A1 Farnesyltransferase inhibitors |
| 09/26/2002 | WO2002074738A2 Spiro-cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteinases and tnf-alpha converting enzyme (tage) |
| 09/26/2002 | WO2002074726A2 Aniline derivatives useful as phosphodiesterase 4 inhibitors |
| 09/26/2002 | WO2002074342A1 Remedies for arteriosclerosis |
| 09/26/2002 | WO2002074036A2 Substituted benzopyranones as telomerase inhibitors |
| 09/26/2002 | WO2002038544A3 3-substituted oxindole beta 3 agonists |
| 09/26/2002 | WO2002036173A3 Simultaneous dual isotope imaging of cardiac perfusion and cardiac inflammation |
| 09/26/2002 | WO2002032872A8 Nitrogenous aromatic ring compounds |
| 09/26/2002 | WO2002030922A3 Dioxolane analogs for improved inter-cellular delivery |
| 09/26/2002 | WO2002024666A3 4-amino-quinazolines |
| 09/26/2002 | WO2002024636A3 N-acylsulfonamide apoptosis promoters |
| 09/26/2002 | WO2001072743A1 Triazole compounds having amide linkage |
| 09/26/2002 | US20020137938 Novel process |
| 09/26/2002 | US20020137932 Treating autoimmune diseases, Alzheimer's disease, atherosclerosis, osteoporosis, and asthma |
| 09/26/2002 | US20020137931 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications |
| 09/26/2002 | US20020137929 1 - (3-heterocyclylphenyl) isothiourea, -isourea, -guanidine and -amidine herbicidal agents |
| 09/26/2002 | US20020137770 Piperidine derivatives |
| 09/26/2002 | US20020137769 Imidazole derivatives having an inhibitory activity for farnesyl transferase and process for preparation thereof |
| 09/26/2002 | US20020137766 Electrophysiological activity |
| 09/26/2002 | US20020137747 Block cytokine production via inhibition of p38 kinase; triamino-s-triazine compounds; treating rheumatoid arthritis |
| 09/26/2002 | US20020137744 Metalloprotease inhibitors |
| 09/26/2002 | US20020137734 N-hydroxy-2-(2-(((4-((2-methyl-4-quinolinyl)methoxy)phenyl) -sulfonyl)methyl)-2-pyrrolidinyl)acetamide, for example and other quinoline containing N-hydroxyacetamide derivatives |
| 09/26/2002 | US20020137687 Novel compounds that inhibit tryptase activity |
| 09/26/2002 | US20020137664 Substituted piperidines as melanocortin-4 receptor agonists |
| 09/26/2002 | CA2444526A1 Metalloproteinase inhibitors |
| 09/26/2002 | CA2440632A1 Metalloproteinase inhibitors |
| 09/26/2002 | CA2440631A1 Metalloproteinase inhibitors |
| 09/26/2002 | CA2440475A1 Metalloproteinase inhibitors |
| 09/26/2002 | CA2440106A1 Substituted benzopyranones as telomerase inhibitors |
| 09/26/2002 | CA2439539A1 Spiro-cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteinases and tnf-alpha converting enzyme (tage) |
| 09/26/2002 | CA2435847A1 Aniline derivatives useful as phosphodiesterase 4 inhibitors |
| 09/26/2002 | CA2430619A1 Farnesyltransferase inhibitors |
| 09/26/2002 | CA2404701A1 Triazole compounds having amide linkage |
| 09/25/2002 | EP1243583A1 Heterocyclic compounds having sulfonamide groups |
| 09/25/2002 | EP1243582A1 Quinoline and quinazoline derivatives and drugs containing the same |
| 09/25/2002 | EP1243581A1 Pyridinium compounds useful for the treatment of AGE-related diseases |
| 09/25/2002 | EP1243579A1 Process for the production of pyridine derivatives |
| 09/25/2002 | EP1242426A1 Gamma-hydroxy-2-(fluoroalkylaminocarbonyl)-1-piperazinepentanamides as hiv protease inhibitors |
| 09/25/2002 | EP1242410A1 Novel compounds |
| 09/25/2002 | EP1242409A2 Substituted bisindolylmaleimides |
| 09/25/2002 | EP1242406A1 Novel compounds |
| 09/25/2002 | EP1242402A2 Novel compounds |
| 09/25/2002 | EP1242400A1 Pyrrolidine derivatives as cyclic amp-specific phosphodiesterase inhibitors |
| 09/25/2002 | EP1242389A2 Novel branched substituted amino derivatives of 3-amino-1-phenyl-1h[1,2,4]triazol, methods for producing them and pharmaceutical compositions containing them |
| 09/25/2002 | EP1242385A1 Cytokine, especially tnf-alpha, inhibitors |
| 09/25/2002 | EP1242378A1 Novel processes |
| 09/25/2002 | EP1242081A1 Caspases and apoptosis |
| 09/25/2002 | EP1242076A1 2-benzyl and 2-heteroaryl benzimidazole nmda/nr2b antagonists |
| 09/25/2002 | EP1242075A2 Indole compounds |
| 09/25/2002 | EP1157020B1 Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ols, method for producing them and their use as medicaments |
| 09/25/2002 | EP1021405B1 Azetidinone derivatives for the treatment of hcmv infections |
| 09/25/2002 | EP0923570B1 Pyridyl alkene- and pyridyl alkine- acid amides as cytostatics and immunosuppressives |
| 09/25/2002 | EP0912534B1 Muscarinic antagonists |
| 09/25/2002 | EP0835257B1 Intermediates and process for the manufacture of camptothecin derivatives (cpt-11) and related compounds |
| 09/25/2002 | EP0817782B1 Phenyl derivatives useful as endothelin receptor antagonists |
| 09/25/2002 | EP0815089B1 Biphenyl-substituted triazines as light stabilizer |
| 09/25/2002 | CN1371371A Novel derivatives of flavones, xanthones and coumarins |
| 09/25/2002 | CN1371370A Chalcone coumarins |
| 09/25/2002 | CN1371365A Piperidine alcohols |
| 09/25/2002 | CN1371286A Use of cyclooxygenase-2 inhibitor matrix metallappoteinase inhibitor antineoplastic agent and optionally radiation as combination treatment of neoplasia |
| 09/25/2002 | CN1091349C N-(heterocycloformyl) sulfonamide herbicide |
| 09/24/2002 | US6455581 Inhibitors of hiv protease. |
| 09/24/2002 | US6455573 Synthesizing salacinol, its stereoisomers, and non-naturally occurring selenium and nitrogen analogues thereof |
| 09/24/2002 | US6455571 Inhibitors of neuraminidases |
| 09/24/2002 | US6455561 Administering benzofuran derivative for therapy of disease state that is capable of being modulated by inhibition of phosphodiesterase iv or tumour necrosis factor |
| 09/24/2002 | US6455545 Gastrointestinal disorders |
| 09/24/2002 | US6455535 Insecticides |
| 09/24/2002 | US6455530 2R,4S,S,S- and 2S,4R,S,S-hydroxyitraconazole |
| 09/24/2002 | US6455525 Heterocyclic substituted pyrazolones |
| 09/24/2002 | US6455523 Inhibitors of farnesyl protein transferase |
| 09/24/2002 | US6455520 Benzamide derivatives and their use as cytokine inhibitors |
| 09/24/2002 | US6455507 Benzimidazole derivatives |
| 09/24/2002 | US6455502 Compounds and compositions as protease inhibitors |
| 09/24/2002 | US6455472 Herbicides, acaricides, nematicides and insecticides for crops |
| 09/24/2002 | CA2261426C Benzimidazole cyclooxygenase-2-inhibitors |
| 09/20/2002 | WO2001070704A1 Novel imidazole derivatives with anti-inflammatory activity |
| 09/20/2002 | WO2001070692A2 Heterocyclic acylsulfimides, a method for their production, agents containing the same and their use as pesticides |
| 09/20/2002 | WO2001070687A1 Indoles for treating diseases that can be treated using thyroid hormones |
| 09/20/2002 | CA2403807A1 Heterocyclic acylsulfimides,processes for their preparation,compositionscomprising them and their use as pesticides |
| 09/20/2002 | CA2403806A1 Indoles for treating diseases that can be treated using thyroid hormones |
| 09/20/2002 | CA2403732A1 Novel imidazole derivatives with anti-inflammatory activity |
| 09/19/2002 | WO2002073208A2 Anti-epileptogenic agents |
| 09/19/2002 | WO2002072577A2 Azacycloalkyl substituted acetic acid derivatives for use as mmp inhibitors. |
| 09/19/2002 | WO2002072576A1 Benzimidazole anti-inflammatory compounds |
| 09/19/2002 | WO2002072571A2 Pyridinyl pyrazoles useful for the treatment of copd |
| 09/19/2002 | WO2002072570A2 Non-imidazole compounds as histamine h3 antagonists |
| 09/19/2002 | WO2002072567A2 Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| 09/19/2002 | WO2002072564A1 N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same |
| 09/19/2002 | WO2002072556A1 Novel diaminopyrazole derivatives and dyes containing said compounds |
| 09/19/2002 | WO2002072549A1 Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor |
| 09/19/2002 | WO2002072093A2 Use of dual h3/m2 antagonists with a bipiperidinic structure in the treatment of cognition deficit disorders |
| 09/19/2002 | WO2002055519A3 Novel process for the synthesis of 5-(4-fluorophenyl)-1-[2-((2r, 4r)-4-hydroxy -6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1h-pyrrole-3-carboxylic acid phenylamide |
| 09/19/2002 | WO2001007020A3 Carboxylic acid amides, medicaments containing these compounds and the use and production thereof |
| 09/19/2002 | US20020133026 Novel process for the synthesis of 5-(4-fluorophenyl)-1-[2-((2r,4r)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1h-pyrrole-3-carboxylic acid phenylamide |
| 09/19/2002 | US20020133023 Antitumor agents, osteoporosis |
| 09/19/2002 | US20020133018 Calcium channel blockers; cardiovascular disorders; side effect reduction |
| 09/19/2002 | US20020133017 Chromatographic separation of enantiomers of lactones |